Jones Financial Companies Lllp Lowers stake in Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific (TMO) : Jones Financial Companies Lllp reduced its stake in Thermo Fisher Scientific by 6.46% during the most recent quarter end. The investment management company now holds a total of 53,960 shares of Thermo Fisher Scientific which is valued at $7,987,159 after selling 3,728 shares in Thermo Fisher Scientific , the firm said in a disclosure report filed with the SEC on Nov 14, 2016.Thermo Fisher Scientific makes up approximately 0.03% of Jones Financial Companies Lllp’s portfolio.

Other Hedge Funds, Including , Glg reduced its stake in TMO by selling 1,613 shares or 11.21% in the most recent quarter. The Hedge Fund company now holds 12,778 shares of TMO which is valued at $1,891,400. Thermo Fisher Scientific makes up approx 0.16% of Glg’s portfolio.New York State Common Retirement Fund boosted its stake in TMO in the latest quarter, The investment management firm added 64,655 additional shares and now holds a total of 1,239,067 shares of Thermo Fisher Scientific which is valued at $188,102,761. Thermo Fisher Scientific makes up approx 0.28% of New York State Common Retirement Fund’s portfolio.Pillar Pacific Capital Management reduced its stake in TMO by selling 1,213 shares or 2.09% in the most recent quarter. The Hedge Fund company now holds 56,715 shares of TMO which is valued at $8,312,718. Thermo Fisher Scientific makes up approx 1.37% of Pillar Pacific Capital Management’s portfolio.Assetmark Inc boosted its stake in TMO in the latest quarter, The investment management firm added 102 additional shares and now holds a total of 4,940 shares of Thermo Fisher Scientific which is valued at $724,056. Thermo Fisher Scientific makes up approx 0.01% of Assetmark Inc’s portfolio.Bright Rock Capital Management reduced its stake in TMO by selling 40 shares or 0.28% in the most recent quarter. The Hedge Fund company now holds 14,000 shares of TMO which is valued at $2,060,940. Thermo Fisher Scientific makes up approx 0.67% of Bright Rock Capital Management’s portfolio.

Thermo Fisher Scientific closed down -3.07 points or -2.06% at $145.81 with 26,31,666 shares getting traded on Monday. Post opening the session at $148.77, the shares hit an intraday low of $145.63 and an intraday high of $149.2 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, Thermo Fisher Scientific reported $2.03 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Oct 27, 2016. Analyst had a consensus of $1.97. The company had revenue of $4491.00 million for the quarter, compared to analysts expectations of $4393.47 million. The company’s revenue was up 8.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.80 EPS.

Investors should note that on Nov 10, 2016, Thermo Fisher Scientific announced a cash dividend of $0.1500. The company’s management has announced Dec 13, 2016 as the ex-dividend date and fixed the record date on Dec 15, 2016. The payable date has been fixed on Jan 16, 2017.

Many Wall Street Analysts have commented on Thermo Fisher Scientific. Thermo Fisher Scientific was Resumed by Leerink Partners to “Outperform” on Nov 10, 2016. JP Morgan Resumed Thermo Fisher Scientific on Sep 22, 2016 to “Overweight”, Price Target of the shares are set at $180.Thermo Fisher Scientific was Downgraded by Cleveland Research to ” Neutral” on Sep 9, 2016.

Thermo Fisher Scientific Inc. is a provider of analytical instruments equipment reagents and consumables software and services for research manufacturing analysis discovery and diagnostics. The company operates through four segments: Life Sciences Solutions provides reagents instruments and consumables used in biological and medical research discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments provides instruments consumables software and services that are used in the laboratory; Specialty Diagnostics offers diagnostic test kits reagents culture media instruments and associated products and Laboratory Products and Services offers self-manufactured and sourced products for the laboratory.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Thermo Fisher Scientific - Is it time to Sell?

Top Brokerage Firms are advising their investors on Thermo Fisher Scientific. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.